Bioneutral Group Inc (BONU) Financial Statements (2023 and Earlier)

Company Profile

Business Address 211 WARREN STREET
NEWARK, NJ 07103
State of Incorp. NV
Fiscal Year End October 31
Industry (SIC) 281 - Industrial Inorganic Chemicals (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

Current Assets
Cash, cash equivalents, and short-term investments11
Cash and cash equivalents11
Inventory, net of allowances, customer advances and progress billings143
Total current assets:255
Noncurrent Assets
Property, plant and equipment01
Intangible assets, net (including goodwill)9,2499,958
Intangible assets, net (excluding goodwill)9,2499,958
Other noncurrent assets3
Prepaid expense and other noncurrent assets14
Total noncurrent assets:9,2529,973
TOTAL ASSETS:9,2779,978
Current Liabilities
Accounts payable and accrued liabilities, including:1,088975
Other undisclosed accounts payable and accrued liabilities1,088975
Deferred compensation liability979168
Derivative instruments and hedges, liabilities129 
Due to related parties5870
Other undisclosed current liabilities75417
Total current liabilities:2,5961,630
Noncurrent Liabilities
Other undisclosed noncurrent liabilities1,462788
Total noncurrent liabilities:1,462788
Total liabilities:4,0592,418
Temporary equity, carrying amount00
Stockholders' equity
Stockholders' equity attributable to parent, including:5,3797,451
Common stock31
Additional paid in capital63,40363,991
Accumulated deficit(57,889)(54,968)
Other undisclosed stockholders' equity attributable to parent(137)(1,574)
Stockholders' equity attributable to noncontrolling interest(161)109
Total stockholders' equity:5,2197,560
Other undisclosed liabilities and equity(0)(0)

Income Statement (P&L) ($ in thousands)

Cost of revenue(15)(2)
Gross profit:72
Operating expenses(3,073)(2,542)
Operating loss:(3,066)(2,540)
Nonoperating expense(125) 
Investment income, nonoperating379 
Interest and debt expense(216)(66)
Other undisclosed income from continuing operations before equity method investments, income taxes2160
Loss from continuing operations before income taxes:(3,191)(2,606)
Income tax expense (2,305)
Loss before gain (loss) on sale of properties:(3,191)(4,911)
Other undisclosed net income 2,305
Net loss:(3,191)(2,606)
Net income attributable to noncontrolling interest269220
Net loss available to common stockholders, diluted:(2,921)(2,386)

Comprehensive Income ($ in thousands)

Net loss:(3,191)(2,606)
Comprehensive loss:(3,191)(2,606)
Comprehensive loss, net of tax, attributable to noncontrolling interest(269)(220)
Comprehensive loss, net of tax, attributable to parent:(3,460)(2,826)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios


Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: